Better Biotech Stock to Buy With $1,500 Right Now: Viking Therapeutics vs. Summit Therapeutics

Viking Therapeutics (NASDAQ: VKTX) and Summit Therapeutics (NASDAQ: SMMT) are both up-and-coming biotechs with no sales revenue, plenty of cash in the bank, big catalysts on the horizon, and pipeline strategies that could place them in major markets relatively soon.

admin